Vamshi Muddu
YOU?
Author Swipe
View article: 463eP Evaluation of efficacy of definitive chemo-radiation in inoperable carcinoma esophagus
463eP Evaluation of efficacy of definitive chemo-radiation in inoperable carcinoma esophagus Open
View article: 335eP Real-world study of immunotherapy and trastuzumab for HER2-positive biliary tract cancers
335eP Real-world study of immunotherapy and trastuzumab for HER2-positive biliary tract cancers Open
View article: Rare Case of Isolated Intestinal Perforation in a Case of Penetrating Posterior Stab Wound to Gluteal Region: A Case Report
Rare Case of Isolated Intestinal Perforation in a Case of Penetrating Posterior Stab Wound to Gluteal Region: A Case Report Open
View article: Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India
Gemcitabine Cisplatin and Durvalumab Experience in Advanced Biliary Tract Cancers: A Real-World, Multicentric Data From India Open
PURPOSE Biliary tract cancers (BTCs) are usually diagnosed in advanced stages, where treatment options are either palliative chemotherapy and/or best supportive care. The breakthrough results of the TOPAZ-1 trial demonstrated a 24% decreas…
View article: 79P Relevance of combined positive score (CPS) & low-dose immune checkpoint inhibitors (ICIs) in microsatellite stable (MSS) advanced gastric adenocarcinoma (GC): A multi-institution analysis
79P Relevance of combined positive score (CPS) & low-dose immune checkpoint inhibitors (ICIs) in microsatellite stable (MSS) advanced gastric adenocarcinoma (GC): A multi-institution analysis Open
View article: Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy
Olanzapine as Antiemetic Prophylaxis in Moderately Emetogenic Chemotherapy Open
Importance The role of olanzapine has not been adequately evaluated in moderately emetogenic chemotherapy (MEC) regimens with or without neurokinin-1 receptor antagonists. Objective To evaluate whether addition of olanzapine to an MEC regi…
View article: Landscape of cancer clinical trials in India – a comprehensive analysis of the Clinical Trial Registry-India
Landscape of cancer clinical trials in India – a comprehensive analysis of the Clinical Trial Registry-India Open
Pi Health USA, a fully owned subsidiary of BeiGene Ltd.
View article: State of Cancer Care in India and Opportunities for Innovation
State of Cancer Care in India and Opportunities for Innovation Open
Cancer is one of the leading causes of morbidity and mortality in India. Despite recent medical and technological advances, the cancer burden in India remains high and continues to rise. Moreover, substantial regional disparities in cancer…
View article: Hepatocellular carcinoma in India: Time for a new focus
Hepatocellular carcinoma in India: Time for a new focus Open
We read with interest the article by Parveen et al. in the current issue of the journal, discussing the presentation and treatment of hepatocellular carcinoma at the Sher-i-Kashmir Institute of Medical Sciences (SKIMS), a tertiary care cen…
View article: P-209 Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers
P-209 Real-world study of durvalumab and chemotherapy in Indian patients with advanced biliary tract cancers Open
View article: P-371 Docetaxel-based perioperative chemotherapy in gastric and gastroesophageal (GEJ) adenocarcinomas – a real world experience from a tertiary cancer centre in India
P-371 Docetaxel-based perioperative chemotherapy in gastric and gastroesophageal (GEJ) adenocarcinomas – a real world experience from a tertiary cancer centre in India Open
View article: Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline
Survey of Implementation of Antiemetic Prescription Standards in Indian Oncology Practices and Its Adherence to the American Society of Clinical Oncology Antiemetic Clinical Guideline Open
Purpose Adherence to international antiemetic prophylaxis guidelines like those of ASCO can result in better control of chemotherapy-induced nausea and vomiting; however, the extent of implementation of such guidelines in India is unknown.…
View article: Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre Open
Objective: To determine the efficacy and safety of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) patients from the named patient programme (NPP) at our centre. Methods: mCRPC patients wh…
View article: Title Page / Table of Contents
Title Page / Table of Contents Open
View article: Supplementary Material for: Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre
Supplementary Material for: Cabazitaxel for Metastatic Castration-Resistant Prostate Cancer: Retrospective Data Analysis from an Indian Centre Open
Objective: To determine the efficacy and safety of cabazitaxel in metastatic castration-resistant prostate cancer (mCRPC) patients from the named patient programme (NPP) at our centre. Methods: mCRPC patients who progressed o…
View article: Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance
Compliance With Neoadjuvant Chemotherapy in T4 Oral Cancers: Place, Person, Socioeconomic Status, or Assistance Open
Purpose Approximately 15% to 20% of our patients with head and neck cancer receiving neoadjuvant chemotherapy (NACT) discontinue therapy because of various nonmedical reasons. We sought to analyze the factors associated with treatment defa…